Australia markets open in 2 hours 18 minutes

Zydus Lifesciences Limited (ZYDUSLIFE.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
1,069.05-11.30 (-1.05%)
At close: 03:30PM IST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
Total revenue
200,152,000
190,215,000
168,778,000
148,276,000
141,250,000
Cost of revenue
64,121,000
65,004,000
65,589,000
58,189,000
50,708,000
Gross profit
136,031,000
125,211,000
103,189,000
90,087,000
90,542,000
Operating expenses
Research development
-
1,558,000
1,358,000
1,146,000
1,250,000
Selling general and administrative
-
21,756,000
21,401,000
18,014,000
18,125,000
Total operating expenses
85,223,000
79,816,000
74,640,000
65,320,000
63,168,000
Operating income or loss
50,808,000
45,395,000
28,549,000
24,767,000
27,374,000
Interest expense
581,000
440,000
1,255,000
1,144,000
1,559,000
Income before tax
53,794,000
48,089,000
25,897,000
28,381,000
23,992,000
Income tax expense
11,975,000
9,775,000
5,878,000
5,117,000
1,936,000
Income from continuing operations
42,977,000
39,498,000
20,965,000
23,726,000
22,530,000
Net income
41,925,000
38,595,000
19,603,000
44,873,000
21,336,000
Net income available to common shareholders
41,925,000
38,595,000
19,603,000
44,873,000
21,336,000
Basic EPS
27.74
38.14
19.30
43.83
20.84
Diluted EPS
27.74
38.14
19.30
43.83
20.84
Basic average shares
1,012,012
1,011,927
1,015,650
1,023,743
1,023,743
Diluted average shares
1,012,012
1,011,927
1,015,650
1,023,743
1,023,743